Common StockProspectus Supplement • February 3rd, 2022
Contract Type FiledFebruary 3rd, 2022In December 2020, we entered into a Controlled Equity OfferingSM Sales Agreement, or sales agreement, with Cantor Fitzgerald & Co., or Cantor Fitzgerald, relating to shares of our common stock, $0.001 par value per share. During the first quarter of 2021, we sold an aggregate of $37.3 million of shares of our common stock of the $100.0 million initially offered for sale pursuant to the terms of a prospectus supplement dated December 31, 2020 to our prospectus dated September 14, 2020. In accordance with the terms of the sales agreement, we are filing this prospectus supplement and the accompanying prospectus to permit us to offer and sell from time to time up to the remaining $62.7 million of shares of our common stock through Cantor Fitzgerald, acting as sales agent.